Av
När Chrontech Pharma presenterade sin årsredovisning för 2010 flaggade revisorn för att bolagets kapital endast skulle räcka till och med andra kvartalet 2011. Sedan dess har Chrontech Pharma tagoit in kapital genom emissioner men kapitaltillskottet räcker bara för att hålla igång bolaget fram till och med andra kvartalet 2012.
I årsredovisningen för helåret 2011 redovisar Chrontech Pharma ett resultat efter skatt på -20,2 miljoner kronor. Förlusten har ökat sedan fjolårets rapport då resultatet var -14,6 miljoner kronor. Bolaget hade ingen omsättning för perioden.
Under helåret 2011 har Chrontech Pharma genomfört totalt fyra emissioner. En riktad nyemission hav bolaget 25 miljoner kronor, en kvittningsemission gav 3,1 miljoner kronor och två företrädesemissioner resulterade i totalt 1,4 miljoner kronor.
Styrelsen meddelar att de utvärderar olika alternativ för att finansiera bolagets fortsatta verksamhet. Bolagsstämman hålls i mars.
I årsredovisningen för helåret 2011 redovisar Chrontech Pharma ett resultat efter skatt på -20,2 miljoner kronor. Förlusten har ökat sedan fjolårets rapport då resultatet var -14,6 miljoner kronor. Bolaget hade ingen omsättning för perioden.
Under helåret 2011 har Chrontech Pharma genomfört totalt fyra emissioner. En riktad nyemission hav bolaget 25 miljoner kronor, en kvittningsemission gav 3,1 miljoner kronor och två företrädesemissioner resulterade i totalt 1,4 miljoner kronor.
Styrelsen meddelar att de utvärderar olika alternativ för att finansiera bolagets fortsatta verksamhet. Bolagsstämman hålls i mars.
"We offer effective staffing solutions provided by specialists, we understand a company’s specific needs and we know where to find the best talent." 
"To develop innovative and effective pharmaceuticals within autoimmune/ inflammatory diseases and cancer where major medical need exists" 
"We are entirely devoted to luminescence technology." 
"Our organisation value is to contribute to positioning Scandinavian healthcare and research in absolute world class." 
"To become an internationally leading dental company with innovative, proprietary products of high therapeutic and commercial value." 
"Dilafor is developing new products in the field of obstetrics, to provide an effective solution to the challenge of dystocia or protracted labor"
" 
"Mercodia has been a supplier of reliable assays since 1991" 
"We turn medical research into applications for better health and well-being." 
"To supply Swedish and Danish laboratories with laboratory equipment and furniture of highest quality and offer service on all delivered products." 
"Your global partner of pharmaceutical service and cGMP manufacturing" 
"To be the most attractive node and business platform in the Nordic countries for new and innovative Life Science companies" 
"We have a unique technological platform, built around 5HT-receptor antagonism, for the treatment of inflammation and pain"." 
"Our aim is to be the best drug development partner to the biotechnology and pharmaceutical industry no matter where you are based." 
"We are recognized as a flexible partner with short decision and lead times plus a proven record for the highest quality and cost efficiency." 
"We promise to go the extra mile every day to ensure you receive the highest level of service and value with each shipment you entrust to us." 
"To adapt Competent Authorities´ requirements into opportunities is not just an artform - today it´s a business necessity." 
"Our vision is to become one of the top 10 global providers of scientific instruments; we will get there by striving for market leadership in our respective product and application niches."
" 
"We help our clients create significant business value through scientific expertise." 
"Together with Zacco our clients achieve their business goals through the management of their intellectual property." 
"VWR is a global laboratory distributor of chemicals, life science products, consumables, equipment, instruments, furniture, e-commerce and services" 
"Best in class companies see the value of optimising their business by having an effective strategy for information management and documentation." 
"PCG - a professional full service CRO for your clinical trials.
Powered by Viedoc, globally trusted eCRF, keeping trials within budget and timelines" 
"With our first class products and our committed and skilled colleagues we guarantee our customers the best support in the market, at no extra charge." 
"Our goal is to invest in innovations and develop new unique pharmaceuticals" 
"Innovation takes place when biology meets engineering; ICT is an enabler to solve the needs for increased functionality and reduced cost in Life Science" 
"Our services in ligand-based and structure-based drug design is a cost-efficient alternative for smaller pharmaceutical companies" 
"Our reliability, customer service, global network and integrated technology make World Courier service truly "A service no one else can deliver"." 
"Uppsala BIO is a life science pathfinder. We build ways to make life science flourish, in cooperation with industry, academia, society and healthcare." 
"APL provides high-quality services to Life Science. We are a Dedicated Partner from Discovery to Market." 
"We aim to be the pioneering benchmark in user-friendly software experience in combination with the highest level of quality." 
"Discover your possibilities in one of Europe´s most productive life science regions. Welcome to Stockholm-Uppsala."
" 
"The PolyPeptide Group is a world class manufacturer of peptide active pharmaceutical ingredients." 
"TFS is today the leading European development partner for biopharmaceutical companies in their global clinical development process." 
"Your work is important to us, we are committed to your success.
Innovative tools? Please download the Promega app." 
"Our products enable an increased number of transplants leading to substantial cost savings for society and increased quality of life for patients." 
"Anton Paar is a product and service leader in the field of scientific instruments. We deliver uncompromised quality in everything we do." 
"We are making it more attractive for companies to invest in innovation with reduced corporation tax on profits from patents to 10%." 
"Novel products for CVD treatment and prevention." 
"Medivir is a specialty pharmaceutical company with unique positioning on the Nordic market and our goal is become a profitable company in high growth" 
"Allenex is a life science company that develops, manufactures, markets and sells high quality products for the transplantation market." 
"As a full service CRO with offices in all Nordic countries we can provide our customer with professional support throughout the clinical research." 
"To be acknowledged as the Best-in-Class provider of pharmaceutical development and manufacturing services by customers, employees & other stakeholders" 
